Drug Target Review

AUGUST 29, 2024

Dr Siciliano received a BS in chemistry from Villanova University and shortly thereafter began his scientific career in the Department of Microbiology at the University of Pennsylvania Medical School studying host-pathogen interactions.

Therapies 59

Therapies Treatment Engineering Molecular Biology 59

Drug Target Review

JULY 1, 2024

Dr Hernan Bazan received a BS in molecular biology from Vanderbilt University and has spent two years in medical school as a Howard Hughes Medical Institute (HHMI) Research Scholar at the NIH. He and his team have completed Phase I clinical trials, paving the way for Phase II RCTs in acute and neuropathic pain.

Treatment 59

Treatment Clinical Trials Therapies Molecular Biology 59

PLOS: DNA Science

AUGUST 22, 2024

Crichton had an MD from Harvard Medical School, but he never practiced medicine. TMV is a common pathogen used in early molecular biology research. Michael_Crichton’s output includes The Andromeda Strain, Jurassic Park, Congo, Twister, The Lost World, Prey, Sphere, Westworld, and the TV series ER.

DNA 71

DNA Virus Organic Chemistry Science 71

Codon

JUNE 26, 2023

Future Nobel Laureate, Paul Berg, narrated the video, which quickly became a cult classic moment in molecular biology history. … There was a time when the film was being shown in biology courses from middle school to graduate courses in genetics and biochemistry and even in post graduate education lectures to physicians.

DNA 52

DNA Therapies Engineering Clinical Trials 52

Codon

JUNE 26, 2023

Future Nobel Laureate, Paul Berg, narrated the video, which quickly became a cult classic moment in molecular biology history. … There was a time when the film was being shown in biology courses from middle school to graduate courses in genetics and biochemistry and even in post graduate education lectures to physicians.

DNA 52

DNA Therapies Engineering Clinical Trials 52

Broad Institute

NOVEMBER 20, 2024

Isselbacher Professor of Medicine at Harvard Medical School, director of the Center for Computational and Integrative Biology and member of the Department of Molecular Biology at MGH, and co-director of the Center for Microbiome Informatics and Therapeutics at MIT.

Regulations 84

Regulations Immune Response Molecular Biology Disease 84

Drug Target Review

FEBRUARY 15, 2024

Advances in molecular biology have led to highly safe, efficient, and effective platforms, such as mRNA, that can be rapidly re-purposed for different pathogens, multiple pathogens, or new strains of evolving pathogens. He currently serves as Chief Medical Officer at SIGA Technologies. References Morens D, Fauci A.

Drug Development 122

Drug Development Virus Vaccine Government 122

The Pharma Data

OCTOBER 27, 2021

The appointment also builds on other recent Non-Executive Director appointments, including Charles (Charlie) Bancroft, former Executive Vice President at Bristol Myers Squibb (BMS), and Dr Anne Beal, former instructor in paediatrics at Harvard Medical School and Massachusetts General Hospital, and Chief Patient Officer at Sanofi.

Molecular Biology 52

Molecular Biology Science Medical Schools Disease 52

Broad Institute

JANUARY 7, 2025

At the Broad, Rehm wears many hats: chief medical officer for Broad Clinical Labs, a co-leader of Broads Center for Mendelian Genomics , and head of the Translational Genomics Group , a research effort that aims to understand the genetic basis of rare disease.

Disease 121

Disease Science Laboratories Medical Schools 121

Codon

JANUARY 5, 2025

In 1926, one of Cohn’s academic colleagues at Harvard Medical School discovered that patients suffering from pernicious anemia, a form of vitamin B12 deficiency, could be cured by eating liver. Cohn was the only non-medical researcher invited, and he made a big impression. At the time, the U.S.

Laboratories 89

Laboratories Science Production Research 89